TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS BY PHARMACOLOGICAL TARGETING OF Kv1.3 POTASSIUM CHANNELS
摘要
Activation of brown adipose tissue, treatment of obesity and/or treatment of obesity-related disorders in human or non-human animal subjects by administering to the subject a potassium channel inhibiting agent. The potassium channel inhibiting agent may comprise ShK toxin or a modified ShK toxin. Examples of modified ShK toxins include ShK-186.
申请公布号
EP2763702(A4)
申请公布日期
2015.04.15
申请号
EP20120838795
申请日期
2012.10.02
申请人
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;KINETA ONE, LLC
